conference logo
 
Programme  Titles  Presenters  Topics 
Craniopharyngioma/Rare Tumors
Sunday, July 1, 2:30pm - 3:30pm

 

SESSION CHAIRS: Todd Hankinson, Pratiti Bandopadhayay, Hermann Müller

 

 


CRAN-11 Multiplexed immunofluorescence reveals potential PD-1/PD-L1 pathway vulnerabilities in craniopharyngioma
Shannon Coy*1,2, Rumana Rashid1, Jia-Ren Lin2,3, Ziming Du1, Andrew M. Donson4,5, Todd C. Hankinson5,6, Nicholas K. Foreman4,5, Peter E. Manley2,7, Mark W. Kieran2,7, David A. Reardon2,8, Peter K. Sorger2,3, Sandro Santagata1,9
1Department of Pathology, Brigham and Women's Hospital, USA, 2Harvard Medical School, USA, 3MS LINCS Center and Laboratory of Systems Pharmacology, USA, 4Department of Pediatrics, University of Colorado School of Medicine, USA, 5Morgan Adams Foundation Pediatric Brain Tumor Research Program, USA, 6Department of Neurosurgery, Children's Hospital Colorado, USA, 7Pediatric Medical Neuro-Oncology, Dana-Farber Boston Children's Cancer and Blood Disorders Center, USA, 8Department of Medical Oncology, Dana-Farber Cancer Institute, USA, 9Ludwig Center at Harvard, USA, 10Department of Pathology, Boston Children's Hospital, USA, 11Department of Oncologic Pathology, Dana Farber Cancer Institute, USA
CRAN-34 Transcriptomic and proteomic comparison of pediatric and adult adamantinomatous craniopharyngioma
Eric Prince1,2, Ros Whelan*1,2, Andrew Donson1,2, Susan Staulcup1,2, Kevin Lillehei1, Nicholas Foreman1,2, Luca Massimi4, Michael Handler1,2, Todd Hankinson1,2
1University of Colorado Denver, USA, 2Children's Hospital Colorado, USA, 3Children's Hospital of Alabama, USA, 4Catholic University Rome, Italy
CRAN-17 Tumour compartment transcriptomics demonstrate the activation of inflammatory and odontogenic programmes in human adamantinomatous craniopharyngioma and identify novel therapeutic targets
John Apps*1,2, Romaine Guiho1, Ying Hong1, Darren Hargrave1,2, Paul Brogan1,2, Thomas Jacques1,2, Juan Pedro Martinez-Barbera1
1UCL GOS Institute of Child Health, UK, 2Great Ormond Street Hospital for Children NHS Foundation Trust, UK
CRAN-35 Childhood Cystic Craniopharyngioma: 15 years of intra-tumoral chemotherapy with interferon-alpha at IOP/GRAACC/UNIFESP 
Patricia Dastoli1,2, Jardel Nicácio1,2, Marcos Costa1,2, Andrea Cappellano*1, Nasjla Silva1, Sergio Calvalheiro1,2
1Instituto de Oncologia Pediátrica GRAACC/UNIFESP, Division of Neuroncology, Brazil, 2Universidade Feceral de São Paulo- Discipline of Neurosurgery, Division Neurosurgery Pediatric, Brazil
CRAN-02 Low concordance between surgical and radiological assessment of degree of resection and treatment-related hypothalamic damage – Results of KRANIOPHARYNGEOM 2007
Hermann L. Müller*1, Julia Reichel1, Svenja Boekhoff1, Monika Warmuth-Metz2, Maria Eveslage3, Junxiang Peng4, Jörg Flitsch5
1Dep.of Pediatrics and Pediatric Hematology/Oncology, Klinikum Oldenburg, Medical Campus University Oldenburg, Germany, 2Dep. of Neuroradiology, University Hospital Würzburg, Germany, 3Institute of of Biostatistics and Clinical Research, University Münster, Germany, 4Department of Neurosurgery, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China, 5Department of Neurosurgery, University Hospital Hamburg-Eppendorf (UKE), Germany